NEFL and systemic lupus erythematosus: Hypothetically, an SLE phenotype with renal involvement may constitute a subgroup of lupus patients that is at risk of increased neuroaxonal damage, driven by active disease reflected by anti-dsDNA antibodies and ongoing complement activation, resulting in increased NfL concentrations and MRI abnormalities, as well as overall organ damage.